Monitoring and evaluation of adverse events: the experience at Hospital de Clínicas de Porto Alegre

Authors

  • Lucas Wollmann HCPA
  • Verônica Calleya Bittencourt HCPA
  • Ana Paula da Silva Pedroso HCPA
  • Liciane da Silva Costa HCPA
  • José Roberto Goldim HCPA/UFRGS

Keywords:

Eventos Adversos, Monitoramento

Abstract

Based on national and international regulations, one of the the Research Ethics Committees (REC) have the attribution to protect human beings involved in research. According to these documents, REC should not only review all the research protocols, but also moni-tor adverse events (AE) reported by the investigator. This monitoring activities must be agile and critical, guiding its actions by evaluation of risk/benefit associated to each study. The Grupo de Pesquisa e Pós-Graduação of the Hospital de Clínicas de Porto Alegre (HCPA) introduced, in 2001, the Program of Monitoring of Risks and Adverse Events, developed by the Laboratório de Pesquisa em Bioética e Ética na Ciência.

Downloads

Download data is not yet available.

Published

2008-01-29

How to Cite

1.
Wollmann L, Bittencourt VC, Pedroso AP da S, Costa L da S, Goldim JR. Monitoring and evaluation of adverse events: the experience at Hospital de Clínicas de Porto Alegre. Clin Biomed Res [Internet]. 2008 Jan. 29 [cited 2025 Apr. 29];27(3). Available from: https://seer.ufrgs.br/index.php/hcpa/article/view/2990

Issue

Section

Bioethics

Most read articles by the same author(s)

1 2 3 > >>